Source: Science Translational Medicine. Unidade: FM
Subjects: GLICOPROTEÍNAS, ANTICORPOS, VÍRUS
ABNT
PAHMEIER, Felix et al. Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread. Science Translational Medicine, v. 17, n. 786, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/85239. Acesso em: 04 jan. 2026.APA
Pahmeier, F., Monticelli, S. R., Feng, X., Hjorth, C. K., Wang, A., Kuehne, A. I., et al. (2025). Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread. Science Translational Medicine, 17( 786). doi:10.1126/scitranslmed.adq5928NLM
Pahmeier F, Monticelli SR, Feng X, Hjorth CK, Wang A, Kuehne AI, Bakken RR, Batchelor TG, Lee SE, Duarte Neto AN. Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread [Internet]. Science Translational Medicine. 2025 ; 17( 786):[citado 2026 jan. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/85239Vancouver
Pahmeier F, Monticelli SR, Feng X, Hjorth CK, Wang A, Kuehne AI, Bakken RR, Batchelor TG, Lee SE, Duarte Neto AN. Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread [Internet]. Science Translational Medicine. 2025 ; 17( 786):[citado 2026 jan. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/85239

